Top Institutions in Ophthalmology
Leading academic ophthalmology centers with strong retinal disease research programs and clinical trial experience in novel therapies such as PBM and complement inhibitors are considered. Institutions with FDA trial involvement, translational research in retinal degenerations, and expertise in dry AMD management are prioritized.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as the top ophthalmology center in the US, with extensive research in retinal diseases including AMD and leadership in clinical trials for novel therapies such as photobiomodulation and complement inhibitors.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Mass Eye and Ear is a leader in retinal disease research and clinical innovation, with a strong focus on AMD and emerging therapies including photobiomodulation, supported by collaborations with Harvard Medical School.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a robust retinal research program with expertise in AMD pathophysiology and innovative treatment modalities, including photobiomodulation, supported by strong translational research infrastructure.
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF has a strong clinical and research focus on retinal diseases including dry AMD, with ongoing studies in photobiomodulation and other innovative treatment approaches, supported by a multidisciplinary team.
-
#5
Mayo Clinic Department of Ophthalmology
Rochester, MN
Mayo Clinic is recognized for its comprehensive retinal disease program and clinical research in AMD, including exploration of novel therapies such as photobiomodulation, with a strong emphasis on patient-centered care.